Butterfly Network, Inc.

Butterfly Network, Inc. (NYSE: BFLY) is a medical technology company that completed its public market debut in February 2021 through a merger with GX Acquisition Corp. II, a blank-check company that traded on Nasdaq under the ticker GXII. The transaction was sponsored by entities affiliated with GX Acquisition, positioning Butterfly Network within the healthcare technology sector. The company develops the Butterfly iQ line of AI-powered, handheld ultrasound devices aimed at point-of-care clinical applications. On April 27, 2026, Butterfly Network filed a DEFA14A — additional definitive proxy soliciting materials — with the SEC under accession number 0001140361-26-017120, signaling an active shareholder vote process. Visit SpacDesk and sign up for a free account to access the full filing history, sponsor profile, and post-merger analytics for BFLY.